Clinical trials
Phase 3 Alzheimer Disease trials in Portugal
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 15 |
| Completed | 8 |
| Recruiting | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 6 |
| Pfizer | 5 |
| Bristol-Myers Squibb | 3 |
| Biogen | 2 |
| Eidos Therapeutics, a BridgeBio company | 2 |
| H. Lundbeck A/S | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 |
| AstraZeneca | 1 |
| Eisai Co., Ltd. | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 28 |
| Dementia | 5 |
| Psychomotor Agitation | 3 |
| Amyloid Neuropathies, Familial | 2 |
| Amyloidosis | 2 |
| Cardiomyopathies | 2 |
| Cognitive Dysfunction | 2 |
| Heart Diseases | 2 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.